Chang H, Tao Q, Wei L, Wang Y, Tu C
FASEB J. 2025; 39(2):e70292.
PMID: 39817712
PMC: 11737292.
DOI: 10.1096/fj.202401801RR.
Xue L, Tao Q, Chang H, Yan S, Wang L, Zhao Z
J Inflamm Res. 2025; 18():17-30.
PMID: 39780982
PMC: 11705990.
DOI: 10.2147/JIR.S500101.
Sun H, Wang X, Li Y, Shen Y, Zhang L, Xu Y
Pharmaceutics. 2024; 16(7).
PMID: 39065635
PMC: 11279964.
DOI: 10.3390/pharmaceutics16070938.
Rameshbabu S, Alehaideb Z, Alghamdi S, Suliman R, Almourfi F, Yacoob S
Metabolites. 2024; 14(7).
PMID: 39057691
PMC: 11278686.
DOI: 10.3390/metabo14070368.
Xue X, Sun M, Yan F, Dalbeth N, He Y, Li X
Arthritis Care Res (Hoboken). 2023; 76(5):703-711.
PMID: 38130040
PMC: 11039362.
DOI: 10.1002/acr.25283.
Superiority of Low-Dose Benzbromarone to Low-Dose Febuxostat in a Prospective, Randomized Comparative Effectiveness Trial in Gout Patients With Renal Uric Acid Underexcretion.
Yan F, Xue X, Lu J, Dalbeth N, Qi H, Yu Q
Arthritis Rheumatol. 2022; 74(12):2015-2023.
PMID: 35795968
PMC: 9771863.
DOI: 10.1002/art.42266.
Polyvinylpyrrolidone-Modified Taxifolin Liposomes Promote Liver Repair by Modulating Autophagy to Inhibit Activation of the TLR4/NF-κB Signaling Pathway.
Ding Q, Liu W, Liu X, Ding C, Zhao Y, Dong L
Front Bioeng Biotechnol. 2022; 10:860515.
PMID: 35721857
PMC: 9199375.
DOI: 10.3389/fbioe.2022.860515.
From purines to purinergic signalling: molecular functions and human diseases.
Huang Z, Xie N, Illes P, Di Virgilio F, Ulrich H, Semyanov A
Signal Transduct Target Ther. 2021; 6(1):162.
PMID: 33907179
PMC: 8079716.
DOI: 10.1038/s41392-021-00553-z.
Isoorientin exerts a urate-lowering effect through inhibition of xanthine oxidase and regulation of the TLR4-NLRP3 inflammasome signaling pathway.
An M, Wang M, Shen C, Sun Z, Zhao Y, Wang X
J Nat Med. 2020; 75(1):129-141.
PMID: 33188510
DOI: 10.1007/s11418-020-01464-z.
Concomitant febuxostat enhances methotrexate-induced hepatotoxicity by inhibiting breast cancer resistance protein.
Ikemura K, Hiramatsu S, Shinogi Y, Nakatani Y, Tawara I, Iwamoto T
Sci Rep. 2020; 9(1):20359.
PMID: 31889141
PMC: 6937279.
DOI: 10.1038/s41598-019-56900-2.
-Butyrylated hyaluronic acid ameliorates gout and hyperuricemia in animal models.
Li L, Wang D, Wang X, Bai R, Wang C, Gao Y
Pharm Biol. 2019; 57(1):717-728.
PMID: 31622116
PMC: 8871623.
DOI: 10.1080/13880209.2019.1672755.
Side Effects and Interactions of the Xanthine Oxidase Inhibitor Febuxostat.
Jordan A, Gresser U
Pharmaceuticals (Basel). 2018; 11(2).
PMID: 29799494
PMC: 6027216.
DOI: 10.3390/ph11020051.
Recent Advances in the Histopathology of Drug-Induced Liver Injury.
Kleiner D
Surg Pathol Clin. 2018; 11(2):297-311.
PMID: 29751876
PMC: 5953206.
DOI: 10.1016/j.path.2018.02.009.
ISMP Adverse Drug Reactions: Sildenafil-Induced Erythema Multiforme Acute Liver Injury Due to Febuxostat Intravenous Acetaminophen-Induced Acute Hepatotoxicity Acute Transient Myopia Induced by Zanamivir Lidocaine-Induced Hoigne Syndrome.
Mancano M
Hosp Pharm. 2017; 51(11):884-887.
PMID: 28057946
PMC: 5199219.
DOI: 10.1310/hpj5111-884.
Hyperuricemia-Related Diseases and Xanthine Oxidoreductase (XOR) Inhibitors: An Overview.
Chen C, Lu J, Yao Q
Med Sci Monit. 2016; 22:2501-12.
PMID: 27423335
PMC: 4961276.
DOI: 10.12659/msm.899852.
